References
Abuqwider, J. N., Mauriello, G., & Altamimi, M. (2021). Akkermansia muciniphila, a New Generation of Beneficial Microbiota in Modulating Obesity: A Systematic Review.Microorganisms, 9 (5). doi: 10.3390/microorganisms9051098
Anderson, Per, Carrillo-Gálvez, Ana Belén, & Martín, Francisco. (2015). Isolation of Murine Adipose Tissue-derived Mesenchymal Stromal Cells (mASCs) and the Analysis of Their Proliferation in vitro. Bio-protocol, 5 (21), e1642. doi: 10.21769/BioProtoc.1642
Boone, D.R., Castenholz, R., & Garrity, G. . (2001). Bergey’s Manual of Systematic Bacteriology.Springer–Verlag .
Braunersreuther, V., Viviani, G. L., Mach, F., & Montecucco, F. (2012). Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol, 18 (8), 727-735. doi: 10.3748/wjg.v18.i8.727
Budhwar, S., Verma, P., Verma, R., Rai, S., & Singh, K. (2018). The Yin and Yang of Myeloid Derived Suppressor Cells. Front Immunol, 9 , 2776. doi: 10.3389/fimmu.2018.02776
Cipolla-Neto, J., Amaral, F. G., Afeche, S. C., Tan, D. X., & Reiter, R. J. (2014). Melatonin, energy metabolism, and obesity: a review. J Pineal Res, 56 (4), 371-381. doi: 10.1111/jpi.12137
Crovesy, L., Masterson, D., & Rosado, E. L. (2020). Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr, 74 (9), 1251-1262. doi: 10.1038/s41430-020-0607-6
Cherngwelling, R., Pengrattanachot, N., Swe, M. T., Thongnak, L., Promsan, S., Phengpol, N., et al . (2021). Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in rats.Toxicol Appl Pharmacol, 425 , 115601. doi: 10.1016/j.taap.2021.115601
de Farias, Tdsm, Cruz, M. M., de Sa, Rcdc, Severi, I., Perugini, J., Senzacqua, M., et al . (2019). Melatonin Supplementation Decreases Hypertrophic Obesity and Inflammation Induced by High-Fat Diet in Mice. Front Endocrinol (Lausanne), 10 , 750. doi: 10.3389/fendo.2019.00750
Farias, T., Paixao R.I.D., Cruz M.M., de Sa R., Simao, J.J., Antraco, V.J., Alonso-Vale, M.I.C. Melatonin Supplementation Attenuates the Pro-Inflammatory Adipokines Expression in Visceral Fat from Obese Mice Induced by A High-Fat Diet, Cells 8(9) (2019).
Dhariwal, A., Chong, J., Habib, S., King, I. L., Agellon, L. B., & Xia, J. (2017). MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res, 45 (W1), W180-W188. doi: 10.1093/nar/gkx295
Diez-Echave, P., Vezza, T., Rodriguez-Nogales, A., Ruiz-Malagon, A. J., Hidalgo-Garcia, L., Garrido-Mesa, J., et al . (2020). The prebiotic properties of Hibiscus sabdariffa extract contribute to the beneficial effects in diet-induced obesity in mice. Food Res Int, 127 , 108722. doi: 10.1016/j.foodres.2019.108722
Ellulu, M. S., Patimah, I., Khaza’ai, H., Rahmat, A., & Abed, Y. (2017). Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci, 13 (4), 851-863. doi: 10.5114/aoms.2016.58928
Farias, Tdsm, Paixao, R. I. D., Cruz, M. M., de Sa, Rdcdc, Simao, J. J., Antraco, V. J., & Alonso-Vale, M. I. C. (2019). Melatonin Supplementation Attenuates the Pro-Inflammatory Adipokines Expression in Visceral Fat from Obese Mice Induced by A High-Fat Diet. Cells, 8 (9). doi: 10.3390/cells8091041
Ferreira-Hermosillo, A., Molina-Ayala, M. A., Molina-Guerrero, D., Garrido-Mendoza, A. P., Ramirez-Renteria, C., Mendoza-Zubieta, V., et al. (2020). Efficacy of the treatment with dapagliflozin and metformin compared to metformin monotherapy for weight loss in patients with class III obesity: a randomized controlled trial. Trials, 21 (1), 186. doi: 10.1186/s13063-020-4121-x
Genario, R., Cipolla-Neto, J., Bueno, A. A., & Santos, H. O. (2021). Melatonin supplementation in the management of obesity and obesity-associated disorders: A review of physiological mechanisms and clinical applications. Pharmacol Res, 163 , 105254. doi: 10.1016/j.phrs.2020.105254
Gonzalez, F. J., & Jiang, C. (2017). A Western diet-induced mouse model reveals a possible mechanism by which metformin decreases obesity. Eur J Clin Pharmacol, 73 (10), 1337-1339. doi: 10.1007/s00228-017-2322-3
Gorwood, P., Benichou, J., Moore, N., Wattez, M., Secouard, M. C., Desobry, X., et al . (2020). Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France. Clin Drug Investig, 40 (11), 1009-1020. doi: 10.1007/s40261-020-00957-9
Greenblum, S., Turnbaugh, P. J., & Borenstein, E. (2012). Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A, 109 (2), 594-599. doi: 10.1073/pnas.1116053109
Hayashi, T., Fujita, K., Matsushita, M., Hayashi, Y., Uemura, M., & Nonomura, N. (2019). Metformin inhibits prostate cancer growth induced by a high-fat diet in Pten-deficient model mice. Int J Urol, 26 (2), 307-309. doi: 10.1111/iju.13847
Henagan, T. M., Stefanska, B., Fang, Z., Navard, A. M., Ye, J., Lenard, N. R., & Devarshi, P. P. (2015). Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning. Br J Pharmacol, 172 (11), 2782-2798. doi: 10.1111/bph.13058
Hickie, I. B., & Rogers, N. L. (2011). Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet, 378 (9791), 621-631. doi: 10.1016/S0140-6736(11)60095-0
Hussain, M. M., & Pan, X. (2012). Clock regulation of dietary lipid absorption. Curr Opin Clin Nutr Metab Care, 15 (4), 336-341. doi: 10.1097/MCO.0b013e3283548629
Ji, S., Wang, L., & Li, L. (2019). Effect of Metformin on Short-Term High-Fat Diet-Induced Weight Gain and Anxiety-Like Behavior and the Gut Microbiota. Front Endocrinol (Lausanne), 10 , 704. doi: 10.3389/fendo.2019.00704
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al . (2013). Richness of human gut microbiome correlates with metabolic markers.Nature, 500 (7464), 541-546. doi: 10.1038/nature12506
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003). c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem, 278 (5), 2896-2902. doi: 10.1074/jbc.M208359200
Li, Y., Ma, J., Yao, K., Su, W., Tan, B., Wu, X., et al . (2020). Circadian rhythms and obesity: Timekeeping governs lipid metabolism. J Pineal Res, 69 (3), e12682. doi: 10.1111/jpi.12682
Liu, G., Jiang, Q., Chen, S., Fang, J., Ren, W., Yin, J., et al . (2017). Melatonin alters amino acid metabolism and inflammatory responses in colitis mice. Amino Acids, 49 (12), 2065-2071. doi: 10.1007/s00726-017-2489-z
Loloei, S., Sepidarkish, M., Heydarian, A., Tahvilian, N., Khazdouz, M., Heshmati, J., & Pouraram, H. (2019). The effect of melatonin supplementation on lipid profile and anthropometric indices: A systematic review and meta-analysis of clinical trials. Diabetes Metab Syndr, 13 (3), 1901-1910. doi: 10.1016/j.dsx.2019.04.043
Louis, P., & Flint, H. J. (2017). Formation of propionate and butyrate by the human colonic microbiota.Environ Microbiol, 19 (1), 29-41. doi: 10.1111/1462-2920.13589
Lu, Q., Li, X., Liu, J., Sun, X., Rousselle, T., Ren, D., et al . (2019). AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases. Biosci Rep, 39 (2). doi: 10.1042/BSR20181995
Luther, J., Garber, J. J., Khalili, H., Dave, M., Bale, S. S., Jindal, R., et al. (2015). Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability. Cell Mol Gastroenterol Hepatol, 1 (2), 222-232. doi: 10.1016/j.jcmgh.2015.01.001
Mantele, S., Otway, D. T., Middleton, B., Bretschneider, S., Wright, J., Robertson, M. D., et al . (2012). Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men.PLoS One, 7 (5), e37123. doi: 10.1371/journal.pone.0037123
Milano, W., De Rosa, M., Milano, L., Riccio, A., Sanseverino, B., & Capasso, A. (2013). Successful Treatment with Agomelatine in NES: A Series of Five Cases. Open Neurol J, 7 , 32-37. doi: 10.2174/1874205X20130626001
Muscogiuri, G., Cantone, E., Cassarano, S., Tuccinardi, D., Barrea, L., Savastano, S., et al . (2019). Gut microbiota: a new path to treat obesity. Int J Obes Suppl, 9 (1), 10-19. doi: 10.1038/s41367-019-0011-7
Nogueira, T. C., Lellis-Santos, C., Jesus, D. S., Taneda, M., Rodrigues, S. C., Amaral, F. G., et al.(2011). Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response. Endocrinology, 152 (4), 1253-1263. doi: 10.1210/en.2010-1088
O’Neill, L. A., & Hardie, D. G. (2013). Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature, 493 (7432), 346-355. doi: 10.1038/nature11862
Pu, R., Shi, D., Gan, T., Ren, X., Ba, Y., Huo, Y., et al. (2020). Effects of metformin in obesity treatment in different populations: a meta-analysis. Ther Adv Endocrinol Metab, 11 , 2042018820926000. doi: 10.1177/2042018820926000
Rebai, R., Jasmin, L., & Boudah, A. (2021). Agomelatine effects on fat-enriched diet induced neuroinflammation and depression-like behavior in rats. Biomed Pharmacother, 135 , 111246. doi: 10.1016/j.biopha.2021.111246
Reiter, R. J., Tamura, H., Tan, D. X., & Xu, X. Y. (2014). Melatonin and the circadian system: contributions to successful female reproduction. Fertil Steril, 102 (2), 321-328. doi: 10.1016/j.fertnstert.2014.06.014
Ren, W., Wang, P., Yan, J., Liu, G., Zeng, B., Hussain, T., et al . (2018). Melatonin alleviates weanling stress in mice: Involvement of intestinal microbiota. J Pineal Res, 64 (2). doi: 10.1111/jpi.12448
Rodriguez-Nogales, A., Algieri, F., Garrido-Mesa, J., Vezza, T., Utrilla, M. P., Chueca, N., et al.(2017). Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition.Mol Nutr Food Res, 61 (11). doi: 10.1002/mnfr.201700144
Rovella, V., Rodia, G., Di Daniele, F., Cardillo, C., Campia, U., Noce, A., et al. (2021). Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity. Nutrients, 13 (2). doi: 10.3390/nu13020613
Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013). AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest, 123 (7), 2764-2772. doi: 10.1172/JCI67227
Salminen, A., Hyttinen, J. M., & Kaarniranta, K. (2011). AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (Berl), 89 (7), 667-676. doi: 10.1007/s00109-011-0748-0
Sharma, Mala, McClung, John Arthur, & Abraham, Nader G. (2016). Chapter 4 - Adiponectin: A Mediator of Obesity, Insulin Resistance, Diabetes, and the Metabolic Syndrome. In W. S. Aronow & J. A. McClung (Eds.), Translational Research in Coronary Artery Disease (pp. 33-42). Boston: Academic Press.
Shen, J., Obin, M. S., & Zhao, L. (2013). The gut microbiota, obesity and insulin resistance. Mol Aspects Med, 34 (1), 39-58. doi: 10.1016/j.mam.2012.11.001
Sundara Rajan, S., & Longhi, M. P. (2016). Dendritic cells and adipose tissue. Immunology, 149 (4), 353-361. doi: 10.1111/imm.12653
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016). Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J Hepatol, 65 (3), 589-600. doi: 10.1016/j.jhep.2016.05.013
Teixeira, T. F., Souza, N. C., Chiarello, P. G., Franceschini, S. C., Bressan, J., Ferreira, C. L., & Peluzio Mdo, C. (2012). Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr, 31 (5), 735-740. doi: 10.1016/j.clnu.2012.02.009
WHO. (2019). Obesity and Overweight, World Health Organization.
Wong, J. M., de Souza, R., Kendall, C. W., Emam, A., & Jenkins, D. J. (2006). Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol, 40 (3), 235-243. doi: 10.1097/00004836-200603000-00015
Woo, S. L., Xu, H., Li, H., Zhao, Y., Hu, X., Zhao, J., et al. (2014). Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. PLoS One, 9 (3), e91111. doi: 10.1371/journal.pone.0091111
Wu, S. J., Huang, W. C., Yu, M. C., Chen, Y. L., Shen, S. C., Yeh, K. W., & Liou, C. J. (2021). Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice.J Nutr Biochem, 91 , 108602. doi: 10.1016/j.jnutbio.2021.108602
Xu, P., Yin, K., Tang, X., Tian, J., Zhang, Y., Ma, J., et al. (2019). Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.Biomed Pharmacother, 120 , 109458. doi: 10.1016/j.biopha.2019.109458
Yadav, A., Kataria, M. A., Saini, V., & Yadav, A. (2013). Role of leptin and adiponectin in insulin resistance. Clin Chim Acta, 417 , 80-84. doi: 10.1016/j.cca.2012.12.007
Yin, J., Li, Y., Han, H., Chen, S., Gao, J., Liu, G., et al. (2018). Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice.J Pineal Res, 65 (4), e12524. doi: 10.1111/jpi.12524
Zhang, H. M., & Zhang, Y. (2014). Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res, 57 (2), 131-146. doi: 10.1111/jpi.12162
Zhang, Q., & Hu, N. (2020). Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes, 13 , 5003-5014. doi: 10.2147/DMSO.S286430